Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Antonio Javier Jiménez-López"'
Autor:
Luis Cabezón-Gutiérrez, Ignacio Delgado-Mingorance, María Nabal-Vicuña, Antonio Javier Jiménez-López, Ana Cabezón-Álvarez, Begoña Soler-López
Publikováno v:
Medwave, Vol 18, Iss 03, Pp e7211-e7211 (2018)
Resumen INTRODUCCIÓN Siendo la disnea irruptiva un síntoma muy frecuente en los pacientes oncológicos, no existen recomendaciones precisas para su tratamiento. El objetivo principal del estudio fue analizar qué tratamientos se utilizan en la pr
Externí odkaz:
https://doaj.org/article/516a81cc3bf046ca90450f7823ef32b8
Autor:
Carmen Beato Zambrano, Antonio Javier Jiménez López, Anna Librán Oriol, Gala Serrano Bermúdez, Oliver Higuera Gómez, Pilar Torres, Jose L. Perez, Almudena Sanz Yagüe, Alfredo Paredes Lario, Rodolfo Chicas Sett, Manuel Cobo Dols, Ibone Huerta González, María Isabel Blancas López-Barajas, Alexandra Giraldo Marín, Pedro Sánchez Mauriño, Luis Cabezón Gutiérrez, Diana Moreno Muñoz, Begoña Soler López, Ignacio Delgado Mingorance, Francisco Javier García Navalón
Publikováno v:
BMJ Supportive & Palliative Care
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
ObjectivesOpioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as efficacy and safety of naloxegol, in patients with cancer with OIC.MethodsAn observat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43bf8dbce96b36c670bd2937fdd1078
https://doi.org/10.1136/bmjspcare-2020-002249
https://doi.org/10.1136/bmjspcare-2020-002249
Publikováno v:
Open Journal of Pain Medicine. 4:001-008
Purpose: Breakthrough Pain (BTP) observed in up to 66% of cancer patients, is more common in patients with advanced cancer stages and is usually associated with a poor prognosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2545b199a036334b248828976caec0d0
https://doi.org/10.17352/ojpm.000017
https://doi.org/10.17352/ojpm.000017
Autor:
Antonio Javier Jiménez López, Alfonso Carregal, Mª. Dolores López Alarcón, José Manuel Trinidad Martín-Arroyo, María de Madariaga, Carlos Ferrer Albiach, Javier Arranz, Francisco Villegas Estévez, Almudena Sanz Yagüe
Publikováno v:
Journal of Pain Research. 12:2125-2135
Purpose: We aimed to explore the characteristics, and real-life therapeutic management of patients with breakthrough cancer pain (BTcP) caused by bone metastases in Spain, and to evaluate physicians' opinion of and satisfaction with prescribed BTcP t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4b077ecb334211dfaedb1333db37caa
https://doi.org/10.2147/jpr.s194881
https://doi.org/10.2147/jpr.s194881
Autor:
Paola Pimentel-Cáceres, Antonio Andrés Rueda-Ramos, Begoña Soler-López, Julio José Lambea-Sorrosal, Mª Paola García-Coves, Antonio Javier Jiménez-López, Lara Iglesias-Docampo, Juan Antonio Núñez-Sobrino, Ana Cabezón-Álvarez, Iker López-Calderero, José Luis Firvida-Pérez
Publikováno v:
Open Journal of Pain Medicine. :009-014
Background: During the oncological disease, patients may suffer a special type of pain called breakthrough pain (BTP), defined as a transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fff3e6d9a490cafdd0eba832d019f299
https://doi.org/10.17352/ojpm.000010
https://doi.org/10.17352/ojpm.000010
Autor:
Jose L. Perez, Ibone Huerta González, Natividad Martínez Banaclocha, Juan Pérez Cajaraville, Antonio Javier Jiménez López, Gemma Soler González, Begoña Soler-López, Silvia Forcano Sanjuan, Ana Cabezón Álvarez, César Margarit Ferri
BackgroundThe purpose of this study was to analyse the clinical management and quality of life of frail patients with cancer, chronic pain and breakthrough pain (BTP) and to assess whether treatment was conditioned by their frailty status.Methods Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eeb99af4578d9ef40f23d74b2c4724b
https://doi.org/10.21203/rs.3.rs-390548/v1
https://doi.org/10.21203/rs.3.rs-390548/v1
Autor:
Ana Cabezón Álvarez, Antonio Javier Jiménez López, María Candelas Madariaga Muñoz, Begoña Soler López, Francisco Villegas Estévez
Publikováno v:
Pain Research and Treatment, Vol 2018 (2018)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Objective. The study objective was to assess the quality of life and satisfaction with treatment of patients with chronic neuropathic pain (CNP) who experience breakthrough pain (BTP) and to assess its economic impact. Design. Cross-sectional observa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383516bbea7e5e90e1d546e38f80ebd9
https://doi.org/10.1155/2018/5394021
https://doi.org/10.1155/2018/5394021
Autor:
Concepción Pérez-Hernández, Antonio Javier Jiménez-López, Almudena Sanz-Yagüe, Begoña Soler-López, Javier Mar-Medina, Igor Larrañaga
Publikováno v:
Pain and Therapy
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Introduction Breakthrough pain (BTP) has great repercussions on the quality of life, and on the use of health resources. The scope of BTP costs in cancer patients is unknown. The purpose of this study was to evaluate the economic cost of BTP in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9ae3ac9d94539c98345281ea6007cd
http://europepmc.org/articles/PMC6251832
http://europepmc.org/articles/PMC6251832
Autor:
Antonio Iglesias Rey, Ana Cabezón Álvarez, Antonio Javier Jiménez López, Begoña Soler López, Leticia Iglesias Rey, Miguel Ángel Núñez Viejo, Carmen Areses Manrique
Publikováno v:
Trends in Medicine. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d86efb4b9e90cf9afccc7f42f05607c9
https://doi.org/10.15761/tim.1000198
https://doi.org/10.15761/tim.1000198
Autor:
Alexandra Giraldo-Marín, Oliver Higuera, Luis Cabezón-Gutiérrez, Almudena Sanz-Yagüe, Rodolfo Chicas Sett, Gala Serrano Bermúdez, Pilar Togores, Ignacio Delgado, Francisco Javier García Navalón, Carmen Beato, Pedro Sánchez Mauriño, Ibone Huerta-González, Antonio Javier Jiménez-López, Anna Librán-Oriol, Manuel Cobo Dols, Begoña Soler, Diana Moreno, Alfredo Paredes Lario, José-Luis Fírvida Pérez, Isabel Blancas
Publikováno v:
Journal of Clinical Oncology. 38:e24155-e24155
e24155 Background: Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main objective of this study was to analyze the efficacy and safety of naloxegol in patients with cancer in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbcdbf901d28fc1bb232015fb4397d05
https://doi.org/10.1200/jco.2020.38.15_suppl.e24155
https://doi.org/10.1200/jco.2020.38.15_suppl.e24155